Antidepressant vortioxetine shows potential in treating brain tumors, offering new hope in cancer therapy by targeting tumor growth and enhancing...
Vous n'êtes pas connecté
Brigham's dual-action treatment shows promise in preclinical lung cancer models, enhancing drug delivery and immune response.
Antidepressant vortioxetine shows potential in treating brain tumors, offering new hope in cancer therapy by targeting tumor growth and enhancing...
MRK and Daiichi Sankyo's patritumab deruxtecan shows statistically significant progression-free survival improvement in previously treated...
Results from a preclinical study in mice, and a collaborative clinical study in patients show that the type 2 immune response – associated with...
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers....
Fever boosts immune cell activity but causes mitochondrial damage, highlighting its dual role in enhancing defense while impacting cellular health.
DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) Pipeline Insight, 2024,” report provides comprehensive insights about...
Discover how estrogens stimulate tumor growth in breast cancer, affect immunotherapy efficacy, and anti-estrogen drug-enhancing treatment.
Researchers have made a significant breakthrough in understanding how oral cancer cells evade the body's immune system, leading to potential new...
Stimulating a key metabolic pathway in T cells can make them work more effectively against tumours when combined with immune checkpoint inhibitor...
Researchers at the Francis Crick Institute, UK, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung...